Friday 6 November 2026 Export AVTR’s income statement to Excel — free account

Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue: +4.59%
EPS: +128.9%
Free cash flow: −9.03%
Total debt: −4.51%

Quarter to September 2026, against a year earlier

Insider buying

15.38 0.24 +1.59%

Follow AVTR

Alert me

Market cap: $10.3B
P/E: 30.3×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 1.55
Beneish M: −2.91
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Avantor, Inc. 10-K filed Feb 11, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed Feb 11, 2026 · accepted 7:34 AM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 7, Management’s Discussion and Analysis, against the 10-K filed Feb 7, 2025: 24 added · 37 removed · 46 modified; 14 with only figures updated